KIDS: OrthoPediatrics Corp Analyst Median Target

Corporate company logo of OrthoPediatrics Corp. (KIDS)

OrthoPediatrics Corp. (KIDS) is actively scaling the delivery of unique pediatric orthopedic systems, expanding its presence across global markets. Surgeon loyalty and specialized training create a powerful momentum effect, ensuring stable demand for its products. This market price chart with analyst consensus currently stands at 30.72. The business relies on a narrow specialization in pediatric surgery, maintaining its leadership in this healthcare segment worldwide.

KIDS (OrthoPediatrics Inc.) Price Target Chart history from 07/04/2022 to 11/12/2026

Metric breakdowns and analytics for OrthoPediatrics Corp. (KIDS)

- stock value and consensus price forecast:
General company analysis:KIDS - OrthoPediatrics Corp
Core merchandise of OrthoPediatrics Corp.

Investors often seek a balance between capital preservation and market volatility. The specialization of OrthoPediatrics Corp. (KIDS) in pediatric orthopedic surgery and implants creates a foundation for long-term business resilience. This indicator aggregates expert expectations, reflecting the average fair value of the asset through changes in the consolidated price target for the stock. The line's dynamics demonstrate analysts' reactions to corporate events and financial results. A stable curve reduces risk but may limit returns during sharp market rallies.

Competing companies

Analyst Consensus Forecast bostonscientific.com (BSX)|Analyst Consensus Forecast EW (Edwards Lifesciences Corporation)|Analyst Median Target ResMed Inc (RMD)|OmniPod - Analyst Consensus Forecast|ZBH (Zimmer Biomet Corp) - Broker Consensus Forecast|The Cooper Companies (COO) - Price Target Chart|ALGN - Analyst Median Target|Price Target Chart Globus Medical|TransMedics (TMDX) - Analyst Median Target|Price Target Chart ATEC Spine (ATEC)|AORT: Forecast Levels Chart|Analyst Consensus Forecast ENOV (Enovis Corporation)|integralife.com (IART) - Average Forecast Price|Establishment Labs Holdings Inc. - Analyst Consensus Forecast|Beta Bionics, Inc. (BBNX) - Consensus Target|IRMD: Analyst Consensus Forecast|EMBC - Analyst Median Target|TNDM (Tandem Diabetes Care) - Analyst Consensus Forecast|Analyst Consensus Forecast axogeninc.com|Price Target Chart SI-BONE (SIBN)|Price Target Chart OFIX (Orthofix Medical)|Analyst Consensus Forecast BVS (Bioventus Corp)|Analyst Median Target Treace Corp (TMCI)|SRTA: Consensus Target|Forecast Levels Chart CARL|RXST: Analyst Consensus Forecast|Average Forecast Price ClearPoint Neuro (CLPT)|STXS (Stereotaxis Corp) - Analyst Consensus Forecast|Broker Consensus Forecast STIM (Neuronetics, Inc)|Consensus Target SGHT (Sight Sciences, Inc.)|OBIO (Orchestra BioMed Inc.) - Fair Value Consensus|Price Target Chart Anika Therapeutics, Inc. ANIK|NSPR - Consensus Target|Jin Medical International Ltd - Analyst Consensus Forecast|Average Forecast Price Vivani Medical, Inc.|XTNT: Analyst Consensus Forecast|Broker Consensus Forecast NMTC|MODD (Modular Medical Inc) - Analyst Consensus Forecast|Myomo Inc. (MYO) - Analyst Median Target|Analyst Consensus Forecast COCH|Consensus Target Vivos Therapeutics Inc VVOS|Analyst Consensus Forecast NVNO (enVVeno Medical)|Analyst Consensus Forecast Sintx Technologies Inc SINT|TNON - Price Target Chart|LFWD: Price Target Chart|AMIX (autonomix.com) - Consensus Target|INVO Fertility Corp - Fair Value Consensus|BBLG (Bone Biologics) - Analyst Consensus Forecast|Average Forecast Price axonics.com AXNX|Price Target Chart BIOLASE (BIOL)|dynatronics.com (DYNT) - Analyst Target Range|Paragon 28 - Consensus Target|Analyst Consensus Forecast INVO Bioscience Inc. INVO